Cost-Effectiveness Analysis of Testing for Brca Mutations in Women Diagnosed with Ovarian Cancer and their Female First-Degree Relatives: A Uk Health Service Perspective

Value Health. 2014 Nov;17(7):A643-4. doi: 10.1016/j.jval.2014.08.2327. Epub 2014 Oct 26.
No abstract available